Hims & Hers releases new data on GLP-1s

Hims & Hers released new data showing that its personalized, digital-first approach to weight loss is driving results, laying the groundwork for lasting success. In a U.S. analysis of treatment plans, including compounded GLP-1s, customers taking a compounded GLP-1 reported losing an average of 20.9 pounds or 10.3% of initial body weight, within six months, while reporting a low rate of side effects. Just as importantly, 75% of customers remained on treatment plans in the same timeframe. While dropout rates for commercially available GLP-1s can hover around 80% at six months, only 25% of Hims & Hers customers discontinued treatment in that timeframe. Customers lost an average of 20.9 pounds, or 10.3% of their initial body weight in six months. Among these same customers, only 10.3% reported side effects, and an even smaller 4.5% reported intolerable side effects. Among those who completed a 6-month check-in, 97% of customers on plans with compounded GLP-1s reported an improvement in their overall health.